NCT02183688

Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients

A Double-blind, Randomized, Placebo-controlled Clinical Trial to Confirm the Rationale of the ASA + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,889 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To confirm the combination rationale for the combination of ASA + paracetamol + caffeine compared with the combination of ASA + paracetamol and the individual substances ASA, paracetamol, caffeine, and placebo administered orally to headache patients for two headache episodes

Conditions

• Migraine Disorders

Interventions

Type	Name	Description
DRUG	Low dose ASA
DRUG	High dose ASA
DRUG	Low dose paracetamol
DRUG	High dose paracetamol
DRUG	Caffeine
DRUG	Placebo

Timeline

• Start date: 1998-09-01
• Primary completion: 2003-01-01
• First posted: 2014-07-08
• Last updated: 2014-07-08